These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27372040)
21. Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions. Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC Am J Cardiol; 2018 Dec; 122(12):2035-2042. PubMed ID: 30360886 [TBL] [Abstract][Full Text] [Related]
22. A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance. Boeder NF; Koepp T; Dörr O; Bauer T; Mattesini A; Elsässer A; Möllmann H; Blachutzik F; Achenbach S; Ghanem A; Hamm CW; Nef HM Int J Cardiol; 2016 Oct; 220():706-10. PubMed ID: 27393853 [TBL] [Abstract][Full Text] [Related]
24. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres. Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357 [TBL] [Abstract][Full Text] [Related]
25. Optical Coherence Tomography and Stent Boost Imaging Guided Bioresorbable Vascular Scaffold Overlapping for Coronary Chronic Total Occlusion Lesion. Li H; Rha SW; Choi CU; Oh DJ Yonsei Med J; 2017 Sep; 58(5):1071-1074. PubMed ID: 28792157 [TBL] [Abstract][Full Text] [Related]
26. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography. Danson E; Bhindi R; Hansen P Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696 [No Abstract] [Full Text] [Related]
27. Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics. Blachutzik F; Achenbach S; Marwan M; Röther J; Tröbs M; Schneider R; Nef H; Weissner M; Schlundt C Cardiovasc Revasc Med; 2019 Jun; 20(6):485-491. PubMed ID: 30097188 [TBL] [Abstract][Full Text] [Related]
28. "Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients". Abellas-Sequeiros RA; Ocaranza-Sanchez R; Galvão Braga C; Raposeiras-Roubin S; Lopez-Otero D; Cid-Alvarez B; Souto-Castro P; Trillo-Nouche R; Gonzalez-Juanatey JR Int J Cardiol; 2016 Sep; 219():264-70. PubMed ID: 27343418 [TBL] [Abstract][Full Text] [Related]
30. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance. Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016 [TBL] [Abstract][Full Text] [Related]
31. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry. Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332 [TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update. Toušek P; Kočka V; Malý M; Kozel M; Petr R; Hajsl M; Jarkovský J; Lisa L; Buděšínský T; Widimský P EuroIntervention; 2016 May; 12(1):23-9. PubMed ID: 27173858 [TBL] [Abstract][Full Text] [Related]
33. Coronary artery bifurcation with chronic total occlusion: A "biodegradable" strategy for a challenging treatment with optical coherence tomography analysis. Inga G; Buccheri D; Piraino D; Carella M; Andolina G Int J Cardiol; 2016 Sep; 218():23-24. PubMed ID: 27232906 [No Abstract] [Full Text] [Related]
34. Late neoatherosclerotic scaffold failure: An unexpected achilles heel for current bioresorbable scaffold technology? Hiltrop N; Jorge C; Bennett J; Adriaenssens T Int J Cardiol; 2016 Nov; 223():133-135. PubMed ID: 27537739 [No Abstract] [Full Text] [Related]
35. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population. Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303 [TBL] [Abstract][Full Text] [Related]
36. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study. Vaquerizo B; Barros A; Pujadas S; Bajo E; Estrada D; Miranda-Guardiola F; Rigla J; Jiménez M; Cinca J; Serra A EuroIntervention; 2015 Sep; 11(5):555-63. PubMed ID: 25499833 [TBL] [Abstract][Full Text] [Related]